EZH2 and neoplasm: Results from a small cohort of 69 surgically resected lung adenocarcinomas revealed EZH2 immunopositivity in 63.8% of tumor tissues, and correlation with higher histologic grade and advanced TNM stage, suggesting that EZH2 may contribute to malignant disease progression [8].